ESMO Clinical Practice Guidelines: Genitourinary Cancers

Latest enhanced and revised set of guidelines

ESMO has Clinical Practice Guidelines on the following Urogenital Cancers: Prostate cancer, Bladder cancer, Renal cell cancer (RCC) Penile cancer and Testicular seminoma and non-seminoma. They include information on incidence,  diagnosis, staging and risk assessment,  treatment, response evaluation and follow-up.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings